Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Safety Reporting Systems Will Be Focus Of IoM Medication Errors Cmte. April 14

This article was originally published in The Pink Sheet Daily

Executive Summary

Committee on Identifying and Preventing Medication Errors panel discussion topics for the April 13-15 meeting also include systems design, technology, quality, patient-consumer initiatives and federal and state legislative policy.

You may also be interested in...

IoM Medication Errors Committee Should Estimate Cost Savings, CMS Says

The Institute of Medicine Committee on Drug Safety should provide cost savings estimates in its recommendations on medication errors, the Centers for Medicare & Medicaid Services said

FDA Drug Safety Review Will Consider Pros And Cons Of Separate Safety Agency

The agency is in discussions with the Institute of Medicine to initiate a study on the effectiveness of the drug safety system, particularly in the post-marketing phase. The IoM study is the centerpiece of an FDA drug safety initiative, announced Nov. 5, that packages together ongoing projects.

House Appropriations Subcommittee Plans FDA Hearing July 26

Ag/FDA subcommittee had tabled FDA hearing pending confirmation of a permanent agency commissioner. House cleared FDA 2006 spending in early June.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts